Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mecramine

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 452Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AllianceRx Walgreens Prime Relaunches Exclusive Partnership for Cystaran 0.44%
    AllianceRx Walgreens Prime Relaunches Exclusive Partnership for Cystaran 0.44%

    22 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/alliancerx-walgreens-prime-relaunches-exclusive-partnership-for-the-distribution-of-cystaran-cysteamine-ophthalmic-solution-0-44-301506976.html

    PRNEWSWIRE
    22 Mar 2022
    Share Share
    Avrobio gene therapy shows signs of durability in rare disorder
    Avrobio gene therapy shows signs of durability in rare disorder

    10 Feb 2022

    // V. Singh BENZINGA

    https://www.benzinga.com/general/biotech/22/02/25512694/after-fabry-trial-setback-avrobio-hopes-rebound-with-lysosomal-storage-disorder-data

    V. Singh BENZINGA
    10 Feb 2022
    Share Share
    Recordati Rare Diseases Announces Availability of CYSTADROPS in the U.S.
    Recordati Rare Diseases Announces Availability of CYSTADROPS in the U.S.

    15 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/recordati-rare-diseases-announces-availability-of-cystadrops-cysteamine-ophthalmic-solution-0-37-percent-in-the-u-s-/

    BIOSPACE
    15 Sep 2020
    Share Share
    Recordati to seek Canadian approval for kidney disease drug
    Recordati to seek Canadian approval for kidney disease drug

    18 Apr 2019

    // Allison Martell REUTERS

    https://www.reuters.com/article/us-recordati-canada/recordati-to-seek-canadian-approval-for-kidney-disease-drug-idUSKCN1RS1YP?feedType=RSS&feedName=healthNews

    Allison Martell REUTERS
    18 Apr 2019
    Share Share